[ Price : $8.95]
The Senate Appropriations Committee marks up and approves FDAs fiscal year (FY) 2025 budget, providing a $170 million (2.5%) boost...[ Price : $8.95]
FDA researchers stress the need for more payer involvement in evidence generation to support clinical practice following drug appr...[ Price : $8.95]
FDA approves an Arcutis Biotherapeutics supplemental NDA for Zoryve (roflumilast) cream, 0.15%, for treating mild to moderate atop...[ Price : $8.95]
FDA grants Longeveron a Regenerative Medicine Advanced Therapy designation for Lomecel-B and its use for treating mild Alzheimers ...[ Price : $8.95]
FDA publishes a guidance recommending principles for use in pivotal clinical studies to demonstrate the safety and effectiveness o...[ Price : $8.95]
Kazia Therapeutics says it will meet with FDA about a potential accelerated approval pathway for its glioblastoma drug paxalisib f...[ Price : $8.95]
Federal Register notice: FDA announces an 8/6 public workshop entitled Artificial Intelligence (AI) in Drug & Biological Product D...[ Price : $8.95]
Federal Register: FDA schedules an 8/2 advisory committee meeting to discuss a Zevra Denmark A/S NDA for arimoclomol, indicated fo...